Scientific publications

Journal of Investigative Dermatology, 2025

Molecular, Histological, and Clinical Effects of Selective TYK2 Inhibition with Zasocitinib (TAK-279) in Patients with Moderate-to-Severe Plaque Psoriasis

Choudhury A., Garcet S., Cueto I. et al.

International Journal of Molecular Sciences, 2025

The Proteome of Acute Muscle Pain: Observations from Acute Hypertonic-Saline-Induced Pain in Humans

Jubin P., Amigo M., Boulton D. et al.

Journal of Neuroinflammation, 2025

Characterizing CSF inflammatory proteomics in pediatric post-hemorrhagic hydrocephalus and Anti-NMDAR encephalitis

Broudy T., Bansal A., Pascall A. et al.

Journal of Proteome Research, 2025

Serum Omics Analysis Reveals Tissue Damage and Metabolic Reprogramming in Cavitary Pulmonary Tuberculosis

Wang J., Zhang D., Du C. et al.

iScience, 2025

Ambient temperature exposure on inflammatory blood proteins - a longitudinal self-sampling survey in young Swedish adults

Yu Z., Björkander S., Bendes A. et al.

International Journal of Women's Health, 2025

Relationship Between the Levels of 91 Circulating Inflammatory Proteins and Ovarian-Related Diseases: A Bidirectional Mendelian Randomization Study

Qu J., Zhang L.

Frontiers in Oncology, 2025

A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors

Gill D., Cowey C., Daniels G. et al.

Respiratory Research, 2025

Large scale plasma proteomic profiles improve prediction of idiopathic pulmonary fibrosis in general population

Zhou R., Li G., Zhong Q. et al.

British Journal of Hospital Medicine, 2025

Unraveling the Gut-Oral Axis: A Mendelian Randomization Analysis of Gut Microbiota Impact on Periodontitis via Circulating Inflammatory Proteins

Tang Y., Gao S., Wang Y. et al.

npj Digital Medicine, 2025

Harnessing machine learning for the development, validation, and prognostic evaluation of MASHRisk score: insights from a multicohort study

Ye B., Teng Y., Chen Q. et al.

Advanced Science, 2025

Multi‐Omics Reveal the Dysregulated Gut‐Joint Axis in Knee Synovitis: Data from Two Osteoarthritis Studies in China

Wang X., Liu Y., Sun Z. et al.

International Journal of Infectious Diseases, 2025

Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV

De La Torre Tarazona E., Calderón-Vicente S., Fons-Contreras M. et al.

International Journal of Infectious Diseases, 2025

Intensification with a CCR5 inhibitor at ART initiation Modulates IL-18 and Inflammation-Driven Immune Pathways in People with HIV

Tarazona E., Calderón-Vicente S., Fons-Contreras M. et al.

Journal of Proteome Research, 2025

Multiplex Immune Profiling Reveals the Role of Serum Immune Proteomics in Predicting Response to Radioiodine after Total Resection of Papillary Thyroid Carcinoma

Peng W., Li S., Cao J. et al.

Scientific Reports, 2025

Plasma proteomics to explore benefit from anti-PD-(L)1 in advanced solid tumors: a prospective pilot study

Tikkanen A., Iivanainen S., Karihtala P. et al.

International Journal of Molecular Sciences, 2025

Activation of TSLP–IL-9 Axis Hinders the Antifibrotic Effect of ST2 Deficiency in Pulmonary Fibrosis

Atamas S., Lockatell V., Mei Z. et al.

Cardiovascular Diabetology, 2025

Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)

Tanaka A., Vaduganathan M., Imai T. et al.

Frontiers in Immunology, 2025

New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

Rodero-Romero A., Domínguez-Mozo M., Monreal E. et al.

European Journal of Pharmacology, 2025

Multi-omics analysis reveals the neuroprotective effects of phosphatidylcholine (18:1/18:2) on ischemic stroke by inhibiting plasma IL-18 levels

Wang S., Xiang X., Guo X. et al.

Cancer Discovery, 2025

A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model

Shah U., Cogrossi L., Garces J. et al.